How to Read a PGT Report: From Screening Results to "Can Mosaic Embryos Be Transferred?"

Written by the DanRuo Hospital medical content team | Last updated: 24 October 2026 · This is an educational guide; report interpretation must follow your physician and genetic counselling.

Blastocyst culture, biopsy, sending the samples away... a few weeks later your PGT report arrives, covered with terms like euploid, aneuploid and mosaic, plus a list of chromosome numbers - most people are baffled at first glance. This article walks you through the report item by item: what the three types of PGT each test, what the key fields mean, the most-asked question of whether mosaic embryos can be transferred, and why failure is still possible even when PGT is normal.

1. First, tell the three types of PGT apart: A, M and SR

TypeWhat it testsWho it suits
PGT-AChromosome number abnormalities (aneuploidy)Age over 35, recurrent miscarriage, recurrent implantation failure
PGT-MSpecific single-gene genetic disordersCouples carrying an identified disease-causing gene (e.g. thalassaemia, SMA)
PGT-SRChromosome structural rearrangementsCarriers of structural abnormalities such as chromosomal translocations

Most patients have PGT-A. For the difference between chromosomal disorders and single-gene disorders, see our in-site article "What is the difference between chromosomal and genetic diseases"; a plain-language explanation of the three types of PGT also appears in the final section of the sperm bank selection guide.

2. Key report fields, explained item by item

What is tested: a few cells are taken from the trophectoderm of the day 5-6 blastocyst and screened across 24 chromosome types (22 autosomes + X / Y). The trophectoderm goes on to form the placenta, while the inner cell mass forms the fetus - this point matters when understanding "mosaicism".

Euploid: the chromosome number is normal; these are the embryos to prioritise for transfer.

Aneuploid: the chromosome number is abnormal (one extra = trisomy, one missing = monosomy). Transfer is generally not advised; most such embryos fail to implant or miscarry.

Mosaic: the same embryo contains both chromosomally normal cells and abnormal cells, and the report usually grades the result by the proportion of abnormal cells. This is the most discussed category and the one that most needs expert interpretation.

* Report formats and interpretation thresholds vary slightly between laboratories; always follow the issuing laboratory's documentation and your physician's interpretation.

3. Euploidy rates and age: why the results correlate so strongly with age

Many patients ask "what is your hospital's pass rate?" In fact the PGT pass rate (the euploid embryo rate) is mainly related to the woman's age and has little to do with the hospital. The large study by Franasiak et al. (2014) of 15,169 trophectoderm biopsies (PMID: 24355045) showed:

Female ageEuploid rate (normal)Aneuploid rate
Under 35~60%~40%
35 - 37~45%~55%
38 - 40~35%~65%
41 - 42~15%~85%
43 and over< 10%> 90%

In other words, this step is a bit like "opening a blind box" - the older the woman, the lower the chance of drawing a euploid embryo, which is why older patients often need several cycles to accumulate embryos. For the complete data and Dan Ruo's hospital success rates see PGT pass rates and age; for finer age bands and the literature source see the medical details FAQ.

4. Can mosaic embryos be transferred? (the hot topic - expert interpretation required)

What mosaicism is: errors during the early cell divisions of the embryo leave normal and abnormal cells coexisting within it. Because the biopsy samples the trophectoderm (which becomes the placenta), its proportions do not necessarily represent the inner cell mass (which becomes the fetus) - this is one of the difficulties of interpretation.

Whether transfer is possible depends on three things: (1) the level of mosaicism (low vs high proportion); (2) which chromosome or chromosomes are involved (some chromosomal abnormalities carry higher risk); (3) whether you have euploid embryos to choose from.

General principles (not absolute): when euploid embryos are available, transfer a euploid embryo first; when euploid embryos are insufficient and the mosaic result is low-level and involves lower-risk chromosomes, your physician may consider a mosaic embryo as an alternative, after thorough genetic counselling and informed consent.

Important: the interpretation of mosaicism and the decision whether to transfer are frontier topics where medical evidence is still accumulating; conclusions vary with laboratory standards, the type of mosaicism and individual circumstances. The decision must be individualised by a reproductive physician together with genetic counselling. This article offers no absolute conclusion and should not be used to decide on your own.

5. PGT is normal - so why can miscarriage or failure still happen?

This is the most commonly misunderstood point. PGT-A screens chromosome numbers only; it does not guarantee implantation or the maintenance of pregnancy. A chromosomally normal embryo has only passed the first hurdle; success also depends on endometrial receptivity, the uterine cavity environment, immune and clotting factors, and laboratory and transfer technique, among others (for the systematic work-up see recurrent implantation failure (RIF): the four lines of investigation).

In addition, trophectoderm biopsy has sampling limitations: the trophectoderm and inner cell mass are not necessarily fully consistent, so interpretation error is possible. Overall, the miscarriage rate after transferring a chromosomally normal embryo is significantly lower than with untested embryos - but it is not zero.

6. Per-embryo pricing and its effect on the total cost

Dan Ruo's third-generation IVF single-cycle package includes PGT screening for 8 embryos; if more than 8 are sent, each additional embryo is charged at RMB 3,200 (about US$450-$470), which may be adjusted with exchange rates. The "two-year unlimited retrieval package" (age 38 and under tier) includes 12 PGT tests. The number of embryos sent directly affects the total cost, so discuss it with your physician - good-quality blastocysts are usually tested first. For costs see the cost ranges and the full cost breakdown.

7. When testing happens: trophectoderm biopsy after blastocyst culture

For PGT, embryos must first be cultured to the blastocyst stage (day 5-6); a few cells are then biopsied from the trophectoderm, and the embryo is vitrified (flash-frozen) while awaiting results. Blastocyst culture is itself a selection step - embryos that reach the blastocyst stage generally have better developmental potential (see our article "What is blastocyst culture"). The blastocyst formation rate is related to laboratory standards; Dan Ruo's blastocyst formation rate is about 70% (hospital figures - see PGT pass rates and success rates).

8. A real case: euploid embryos are possible even with low reserve

The in-site case study "AMH 0.77 IVF success story: 3 eggs achieving 100% blastocyst formation and PGT-A pass" is a typical example: ovarian reserve was very low (AMH 0.77) and few eggs were retrieved, yet with the right protocol and laboratory culture, usable euploid embryos were ultimately obtained. This shows that low reserve does not mean no chance - but individual variation is large, the case cannot simply be generalised, and assessment by a physician is required.

Common report questions

Should I have PGT-A, PGT-M or PGT-SR?

Most patients have PGT-A (screening chromosome numbers; suitable for advanced age, recurrent miscarriage and recurrent implantation failure). If one partner carries a clearly identified single-gene disease mutation (such as thalassaemia or SMA), PGT-M is needed; if one partner has a chromosomal structural rearrangement (such as a balanced translocation), PGT-SR is needed. The choice is made by your physician together with genetic counselling and your family history. See also our explainer on the difference between chromosomal and single-gene disorders.

If the report says "mosaic", is the embryo unusable?

Not automatically discarded. Whether to transfer depends on the level of mosaicism, which chromosomes are involved, and whether you have euploid embryos to choose from. When a euploid embryo is available it always comes first; when euploid embryos are insufficient, a low-level mosaic embryo involving lower-risk chromosomes may be considered by your physician as an alternative, after thorough genetic counselling and informed consent. This is a frontier topic where evidence is still accumulating, so the decision must always be individualised by a physician.

Why can miscarriage still happen when PGT is normal?

PGT-A screens chromosome numbers only; it cannot guarantee implantation or the maintenance of pregnancy. Endometrial receptivity, the uterine cavity environment, immune and clotting factors, and the transfer procedure itself - all non-chromosomal factors - can lead to failure or miscarriage, and trophectoderm biopsy has sampling limitations. Transferring a chromosomally normal embryo significantly lowers the miscarriage rate, but not to 100%. Because of sampling representativeness and the limits of testing technology, PGT is not 100% accurate anywhere in the world, and unknown factors within the embryo itself can still cause miscarriage. For a systematic work-up see recurrent implantation failure (RIF).

How many embryos are sent for testing, and how is the extra cost calculated?

Dan Ruo's single-cycle package includes PGT for 8 embryos; beyond that, each additional embryo is charged at RMB 3,200 (about US$450-$470). The "two-year unlimited retrieval package" (age 38 and under tier) includes 12 embryos. How many to test depends on your number of blastocysts and budget - discuss it with your physician; good-quality blastocysts are usually tested first. See the full cost breakdown for details.

Don't choose a clinic on price alone - start with a free preliminary review of your reports and compare plans clearly before deciding. Send your test reports and we provide a free preliminary review with an individualised plan and travel advice. Call +86 400 618 5161 or email info@incitaivf.com, or add a consultant on WeChat / WhatsApp / LINE / Telegram.

Book a one-to-one fertility assessment Cost guide FAQ IVF & PGT detail

This article is general health information and does not constitute medical advice, diagnosis, genetic counselling or a guarantee of any outcome. Decisions on PGT report interpretation and whether to transfer mosaic embryos must follow the issuing laboratory's documentation and the individualised advice of your reproductive physician and genetic counsellor. Age-related data are cited from Franasiak et al. (Fertil Steril 2014, PMID 24355045); success rates and the blastocyst formation rate are the hospital's published figures, and individual variation is large.

Further reading: PGT pass rates and age | Medical details FAQ | Recurrent implantation failure (RIF) | our article on chromosomal vs single-gene disorders (available in Chinese)

400-618-5161
LINE QR code
WhatsApp QR code
WeChat QR code
Telegram QR code